In-house incubation of early-stage companies in healthcare technology, life sciences, and industrial automation — leveraging the Group's existing distribution, regulatory, and clinical infrastructure for rapid, capital-efficient commercialisation.
Waystar Incubator is the Group's internal venture engine — identifying, funding, and building early-stage companies that benefit from the Group's existing operational infrastructure across healthcare, pharma, logistics, and technology.
The incubator applies a distribution-first thesis: companies are selected based on their fit with existing Group channels and relationships, allowing portfolio companies to reach market faster and with lower capital requirements than conventional startup paths. The result is a pipeline of ventures with built-in distribution, regulatory frameworks, and institutional backing from day one.
Waystar Incubator supports early-stage companies with capital access, regulatory navigation, distribution infrastructure (through Waystar Logistics and Life Sciences), and go-to-market support across existing hospital and pharmacy relationships. The current pipeline includes nutraceutical formulations, health technology platforms, and digital health applications.
Pipeline: Omega-3 · Health Tech · Digital Health
Seed and growth-stage funding from within the Group. Portfolio companies access capital without the traditional venture capital fundraising cycle — reducing time-to-market and founder dilution in early stages.
Shared access to Group IT systems, drug licensing frameworks, regulatory expertise, ERP infrastructure, legal templates, and corporate governance — eliminating setup costs that typically consume early-stage capital.
Immediate access to Waystar Logistics' pharmaceutical distribution network, Waystar Life Sciences' wholesale drug licence and e-pharmacy relationships, and hospital connections through Waystar Labs — for qualifying products.
End-to-end commercialisation support: product positioning, physician marketing collateral, digital listing and SEO for e-pharmacy, regulatory dossier preparation, and sales team access through the Group's existing field force.
Early-stage founders in healthcare, life sciences, and health technology are invited to enquire about the incubation programme.